Epigenetics and Obesity

Epigenetic Marks Associated to Severe Obesity

There is growing evidence that DNA methylation might contribute to obesity. Candidate gene methylation studies in animal models and humans have demonstrated methylation changes in promoters of various genes that are implicated in obesity, appetite control and/or metabolism, insulin signaling, immunity, growth and circadian clock regulation. Severe obesity in children …

READ MORE →
CHL1 hypermethylation

CHL1 Hypermethylation in Breast Cancer

Breast cancer (BC) is the most common cancer among women and one of the leading causes of cancer-related deaths worldwide (1-3). It is a clinically heterogeneous disease, with at least 5 different subtypes (4) and quite variable prognosis, even within a subtype. In spite of early detection programmes, unfortunately 20-30% …

READ MORE →
Fibrosis radiation therapy epigenetics

Epigenetic Predisposition to Radiation Fibrosis

Radiotherapy is a highly efficient treatment for many cancers including breast cancer. Intraoperative radiotherapy (IORT), a relatively new type of radiation therapy, has proven successful as a curative treatment for early cancer stages. However, in spite of great improvements in dose delivery and imaging technology, unwanted exposure of healthy tissue …

READ MORE →
Alzheimer’s & the Brain Stem

Epigenetic Dysregulation Within the Brainstem in Alzheimer’s Disease

The elusive nature of the early stages of Alzheimer’s disease (AD) impedes scientific breakthroughs in diagnostics or efficient therapeutics for this devastating disorder. To date, the long-prevailing theories of genetic contribution do not adequately explain the pathogenesis of the disease and, alternatively, epigenetic regulation has been proposed as a key …

READ MORE →
epigenetic mechanisms in allergic diseases

Asthma & Histone Acetylation: an important epigenetic mechanism in allergic diseases

Epigenetic regulation is thought to be one of the most important mechanisms contributing to the development and clinical course of chronic immunological diseases like allergies and asthma. DNA methylation has been extensively studied in this context, which has not been a case of histone modifications such as histone acetylation or …

READ MORE →
ncRNA is Synergistically Regulated by Various Epi-Modifications

Non-coding RNA Expression is Synergistically modulated by Various Types of Epigenetic Modifications

It is well known that most of the mammalian genome is transcribed, producing large amounts of non-coding RNAs (ncRNAs). The two main types of ncRNA are micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs). MiRNAs are a recently discovered and well-characterized class of ncRNAs that are frequently dysregulated in different …

READ MORE →
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

Activated protein C ameliorates diabetic nephropathy (kidney disease) by epigenetically inhibiting the enzyme p66Shc

Activated protein C (aPC) is a serine protease that is lost during diabetes. Previously it has been shown that aPC protects against diabetic nephropathy (dNP)1, a progressive kidney disease caused by damage to the capillaries.  aPC’s cytoprotective effect in diabetic nephropathy may be related to its in vitro ability to …

READ MORE →
Neuroblastoma cells: nuclei are stained in red, microfilaments are in green and in blue

MicroRNA expression is regulated by DNA methylation: a complex cascade of gene regulation events

MicroRNAs (miRNAs) are non-coding RNAs, roughly 22 nucleotides in size that are central and negative regulators of gene expression. They exert their functions through base-pairing with the 3’UTR of mRNAs   and block expression at the transcriptional and post-transcriptional levels, depending on the perfect or imperfect match in sequences between miRNAs …

READ MORE →